Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Side effects of peplomycin].

Y Araki, K Tamura, M Seita

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Continuous infusion of peplomycin with cisplatin and vincristine showed over 70% response in squamous cell carcinoma. Low-dose continuous infusion of peplomycin offers comparable efficacy with reduced toxicity compared to one-shot therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Escherichia coli tRNA(Asp) recognition mechanism differing from that of the yeast system.

    Biochemical and biophysical research communications·1992
    Same author

    Toxic effects of oxygen-derived free radicals on rat pancreatic acini; an in vitro study.

    Hepato-gastroenterology·1992
    Same author

    [A 52-week oral chronic toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethanesulfonate (FUT-187) in rats with a recovery period of 5 weeks.

    The Journal of toxicological sciences·1992
    Same author

    [A 13-week subacute oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in rats].

    The Journal of toxicological sciences·1992
    Same author

    Mixed connective tissue disease associated with protein losing enteropathy: successful treatment with intravenous cyclophosphamide therapy.

    Internal medicine (Tokyo, Japan)·1992
    Same author

    Localized, aggregative, and diffuse adherence to HeLa cells, plastic, and human small intestines by Escherichia coli isolated from patients with diarrhea.

    The Journal of infectious diseases·1992

    Area of Science:

    • Oncology
    • Pharmacology

    Context:

    • Squamous cell carcinoma (SCC) treatment often involves combination chemotherapy.
    • Peplomycin, a chemotherapeutic agent, has been investigated for SCC treatment.

    Purpose:

    • To evaluate the efficacy and toxicity of a combination chemotherapy regimen including cisplatin, vincristine, and peplomycin in patients with SCC.
    • To assess the safety and effectiveness of continuous infusion peplomycin compared to traditional administration methods.

    Summary:

    • Twenty-three SCC patients received cisplatin, vincristine, and peplomycin, achieving an overall response rate exceeding 70%, with one complete remission.
    • Peplomycin was administered via continuous intravenous or subcutaneous infusion using a micro-infusion pump.
    • Common side effects included nausea, vomiting, and hair loss, with local injection site reactions. However, severe toxicities like high fever and pulmonary fibrosis were not observed.

    Related Experiment Videos

    Impact:

    • Continuous low-dose infusion of peplomycin demonstrates comparable antineoplastic activity to one-shot therapy with a more favorable toxicity profile.
    • This administration method may improve patient tolerance and reduce severe adverse events in SCC treatment.